Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 107 recruiting studies, sorted by proximity — each links to its official registry page
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Lancaster, California (2.2 mi)
· Sponsor: Akero Therapeutics, Inc
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Lancaster, California (2.2 mi)
· Sponsor: GlaxoSmithKline
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC
Non-infected Venous Leg Ulcer, Venous Leg Ulcer
N/A
Interventional 60 participants sought
Site 19 — Palmdale, California (8.6 mi)
· Sponsor: BioStem Technologies
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Gastro Care Associates — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Overweight
Phase 3
Interventional 400 participants sought
First Valley Medical Group — Lancaster, California (2.2 mi)
· Sponsor: Novo Nordisk A/S
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
Irritable Bowel Syndrome
Phase 2
Interventional 420 participants sought
GSK Investigational Site — Lancaster, California (2.2 mi)
· Sponsor: GlaxoSmithKline
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference
Colonic Polyps
N/A
Interventional 330 participants sought
Gastro Care Institute — Lancaster, California (2.2 mi)
· Sponsor: Capso Vision, Inc.
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Constipation (IBS-C)
Irritable Bowel Syndrome, Constipation
Phase 2
Interventional 342 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Eli Lilly and Company
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 425 participants sought
Om Research LLC — Lancaster, California (2.2 mi)
· Sponsor: Hoffmann-La Roche
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Om Research — Lancaster, California (2.2 mi)
· Sponsor: Eccogene
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Severe Asthma
Phase 2
Interventional 512 participants sought
Research site — Lancaster, California (2.2 mi)
· Sponsor: Kinaset Therapeutics Inc
Trial to Test the Efficacy of Using Magnetic Fields to Stimulate the Back to Treat Chronic Lower Back Pain.
Lower Back Pain Chronic
N/A
Interventional 88 participants sought
412 Medical Group — Edwards Air Force Base, California (20.6 mi)
· Sponsor: Joe X. Zhang
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features
Phase 3
Interventional 600 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Ulcerative Colitis
Phase 2
Interventional 99 participants sought
Investigational Site Number: 8400006 — Lancaster, California (2.2 mi)
· Sponsor: Sanofi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Lancaster, California (2.2 mi)
· Sponsor: Alnylam Pharmaceuticals
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 3
Interventional 269 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: NRG Oncology
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Episodic Migraine
Phase 3
Interventional 990 participants sought
Chemidox Clinical Trials Inc, Merz Investigational Site #0010488 — Lancaster, California (2.2 mi)
· Sponsor: Merz Therapeutics GmbH
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Juvenile Psoriatic Arthritis
Phase 3
Interventional 60 participants sought
Local Institution - 0038 — Lancaster, California (2.2 mi)
· Sponsor: Bristol-Myers Squibb
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8
N/A
Interventional 150 participants sought
City of Hope Antelope Valley — Lancaster, California (2.2 mi)
· Sponsor: City of Hope Medical Center
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
EDS, Cataplexy
Phase 3
Interventional 258 participants sought
West Coast Pulmonary & Sleep Disorders Center — Lancaster, California (2.2 mi)
· Sponsor: Harmony Biosciences Management, Inc.
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Eosinophilic Asthma
Phase 2
Interventional 264 participants sought
Kymera Investigative Site — Lancaster, California (2.2 mi)
· Sponsor: Kymera Therapeutics, Inc.